Top Law News Biocon, Mylan breast cancer drugs approved by DCGI: HC told March 3, 2017 by Legal India Admin | Leave a Comment Swiss pharma major Roche cannot prima facie have a say against the sale and marketing of breast cancer medicines of drug firms Biocon and Mylan once the Drugs Controller General of India (DCGI) has approved it, Delhi High Court said today. “Once the designated authority has given approval, you cannot say prima facie you have […] Read more ยป Biocon breast cancer medicines Court DCGI Delhi High Court drug firms Drugs Controller General of India featured Law Legal News Mylan
